Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy
The 6th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay was held under the auspices of the Albert B. Sabin Vaccine Institute on March 10–13, 2004. The Colloquium consisted of a select group of 34 scientists representing academia, biotechnology and pharmaceutical industry. Th...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2004
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC441417/ |
| id |
pubmed-441417 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-4414172004-07-02 Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy Kast, W Martin Levitsky, Hyam Marincola, Francesco M Commentary The 6th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay was held under the auspices of the Albert B. Sabin Vaccine Institute on March 10–13, 2004. The Colloquium consisted of a select group of 34 scientists representing academia, biotechnology and pharmaceutical industry. The main goal of this gathering was to promote in a peaceful and comfortable environment exchanges between basic and clinical science. The secondary benefit was to inspire novel bench to bedside ventures and at the same time provide feed back about promising and/or disappointing clinical results that could help re-frame some scientific question or guide the design of future trials. Several topics were covered that included tumor antigen discovery and validation, platforms for vaccine development, tolerance, immune suppression and tumor escape mechanisms, adoptive T cell therapy and dendritic cell-based therapies, clinical trials and assessment of response. Here we report salient points raised by speakers or by the audience during animated discussion that followed each individual presentation. BioMed Central 2004-06-22 /pmc/articles/PMC441417/ /pubmed/15212694 http://dx.doi.org/10.1186/1479-5876-2-20 Text en Copyright © 2004 Kast et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Kast, W Martin Levitsky, Hyam Marincola, Francesco M |
| spellingShingle |
Kast, W Martin Levitsky, Hyam Marincola, Francesco M Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy |
| author_facet |
Kast, W Martin Levitsky, Hyam Marincola, Francesco M |
| author_sort |
Kast, W Martin |
| title |
Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy |
| title_short |
Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy |
| title_full |
Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy |
| title_fullStr |
Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy |
| title_full_unstemmed |
Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy |
| title_sort |
synopsis of the 6th walker's cay colloquium on cancer vaccines and immunotherapy |
| description |
The 6th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay was held under the auspices of the Albert B. Sabin Vaccine Institute on March 10–13, 2004. The Colloquium consisted of a select group of 34 scientists representing academia, biotechnology and pharmaceutical industry. The main goal of this gathering was to promote in a peaceful and comfortable environment exchanges between basic and clinical science. The secondary benefit was to inspire novel bench to bedside ventures and at the same time provide feed back about promising and/or disappointing clinical results that could help re-frame some scientific question or guide the design of future trials. Several topics were covered that included tumor antigen discovery and validation, platforms for vaccine development, tolerance, immune suppression and tumor escape mechanisms, adoptive T cell therapy and dendritic cell-based therapies, clinical trials and assessment of response. Here we report salient points raised by speakers or by the audience during animated discussion that followed each individual presentation. |
| publisher |
BioMed Central |
| publishDate |
2004 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC441417/ |
| _version_ |
1611368860854779904 |